 |
| Highly potent active pharmaceutical ingredients (HPAPIs) are the fastest growing segment in the APIs market. What are the challenges and opportunities for HPAPIs manufacturers? In Challenges & Solutions in Cytotoxins and HPAPIs, learn about the importance of appropriate process design for the commercial manufacture of HPAPIs as well as opportunities for single-use systems. In addition, experts offer a clear explanation of the distinction between cytotoxic cancer drugs and targeted cancer therapeutics. |
|
